Bioinorganic Chemistry
with Medicinal Chemistry, Synthetic Chemistry, Analytical Chemistry, Bioanalytics and Cell Biology
The main emphasis at the Institute of Inorganic Chemistry is put on the subject of Bioinorganic Chemistry, Medicinal Chemistry, Synthetic Chemistry, Analytical Chemistry, Bioanalytics and Cell Biology, mainly focused on the development of novel tumor therapeutics.
The group has successfully contributed to this field for several years. Currently there are two new therapeutics developed in the group under clinical research.
» Research Focus
» Publications
- Univ.-Prof. Dr. Elisa Tomat: Chemistry of transition metals in biology and medicine, Chemical biology and coordination chemistry in anticancer drug design, Synthesis, reactivity, and spectroscopy of new molecules and metal complexes
- Assoc. Prof. Dr. Christian Kowol: Prodrug Development, Drug Delivery Systems, Drug Targeting
- Assoc. Prof. Dr. Samuel Matthias Meier-Menches, Privatdoz: Translational Precision Analytics in Individualized Medicine (in cooperation with Institute of Analytical Chemistry)
- Assoc. Prof. Dr. Michael Reithofer: Biomaterials, Nanochemistry
- ao. Univ.-Prof. Dr. Mathea Galanski: Pt Chemistry, NMR Spectroscopy
- em. o. Univ-Prof. Dr. Dr. Bernhard Keppler: Development of novel anti-cancer drugs
- Dr. Tim Grüne: X-Ray Core Facility
- Dr. Michael Jakupec and Dr. Dina Baier-Romfeld, Cell Culture Facility
- Dipl.-Ing. Dr. Wolfgang Kandioller: Organometallic Chemistry
- Michael Malarek, PhD: Organometallic Chemistry
PhD Students in collaborations
- Center for Cancer Research, Applied and Experimental Oncology, Medical University of Vienna
- Institute of Analytical Chemistry, University of Vienna